Suchergebnisse - "Endometrial Neoplasms pathology"
-
1
Autoren: et al.
Weitere Verfasser: et al.
Quelle: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Instituto de Investigación Sanitaria La Fe (IIS La Fe)Schlagwörter: Adult, Oncologie, Sciences de la santé humaine, Endometrial Neoplasms/pathology, Endometrial Neoplasms/classification, 03 medical and health sciences, 0302 clinical medicine, Sentinel Lymph Node Biopsy/methods, Humans, Sentinel Lymph Node/pathology, Human health sciences, Chirurgie, Endometrial Neoplasms, Sentinel Lymph Node, Neoplasm Staging, Retrospective Studies, Aged, Aged, 80 and over, Sentinel Lymph Node Biopsy, Obstetrics and Gynecology, Reproductive medicine (gynecology, andrology, obstetrics), Middle Aged, Médecine de la reproduction (Gynécologie, andrologie, obstétrique), [SDV] Life Sciences [q-bio], Oncology, Lymphatic Metastasis, Surgery, Female, Endometrial Neoplasms/genetics
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40229079
https://pubmed.ncbi.nlm.nih.gov/39153831
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=21400
https://ijgc.bmj.com/content/34/9/1313
https://doi.org/10.1136/ijgc-2024-005711
https://hdl.handle.net/10281/513843
https://doi.org/10.1136/ijgc-2024-005711
https://hal.univ-lille.fr/hal-04905372v1
https://doi.org/10.1136/ijgc-2024-005711
https://hdl.handle.net/2318/2028432
https://doi.org/10.1136/ijgc-2024-005711 -
2
Autoren: et al.
Quelle: Arch Gynecol Obstet
Schlagwörter: Adult, Aged, 80 and over, Length of Stay/statistics, Aged, 80 and over [MeSH], Aged [MeSH], Endometrial cancer, Endometrial Neoplasms/mortality [MeSH], Hysterectomy/statistics, Germany/epidemiology [MeSH], Neoplasm Staging [MeSH], Lymph Node Excision/statistics, Female [MeSH], Lymphonodectomy, Endometrial Neoplasms/surgery [MeSH], Laparoscopy/adverse effects [MeSH], Adult [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Overall survival, Retrospective Studies [MeSH], Middle Aged [MeSH], Laparoscopy/statistics, Endometrial Neoplasms/pathology [MeSH], Total laparoscopic hysterectomy, Hysterectomy/methods [MeSH], Gynecologic Oncology, Total abdominal hysterectomy, Middle Aged, Length of Stay, Hysterectomy, Endometrial Neoplasms, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Germany, Humans, Lymph Node Excision, Female, Laparoscopy, Retrospective Studies, Aged, Neoplasm Staging
-
3
Autoren:
Quelle: Arch Gynecol Obstet
Schlagwörter: Female [MeSH], Endometrial Neoplasms/surgery [MeSH], Hysterectomy [MeSH], Humans [MeSH], Radiotherapy, Adjuvant/adverse effects [MeSH], Endometrial cancer, Neoplasm Recurrence, Local/pathology [MeSH], Feasibility Studies [MeSH], Neoplasm Staging [MeSH], Endometrial Neoplasms/pathology [MeSH], Endometrial Neoplasms/radiotherapy [MeSH], Sentinel node detection, Peritoneal mesometrial resection, Cancer field surgery, Lymph Node Excision/adverse effects [MeSH], Gynecologic Oncology, Targeted compartmental lymphadenectomy, Medizin, Humans, Feasibility Studies, Lymph Node Excision, Female, Radiotherapy, Adjuvant, Neoplasm Recurrence, Local, Hysterectomy, Neoplasm Staging, Endometrial Neoplasms, 3. Good health
-
4
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Clin Cancer Res
Schlagwörter: Translational Cancer Mechanisms and Therapy, Canada, Endometrial Neoplasms/pathology, 3. Good health, Endometrial Neoplasms, Carcinoma, Endometrioid/pathology, Journal Article, Humans, Tumor Suppressor Protein p53/genetics, Female, Tumor Suppressor Protein p53, Neoplasm Recurrence, Local, Carcinoma, Endometrioid, Retrospective Studies
Dateibeschreibung: application/pdf
-
5
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Invest New Drugs
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Investigational new drugs
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Instituto de Investigación Sanitaria La Fe (IIS La Fe)
Investigational new drugs, vol. 41, no. 5, pp. 677-687Schlagwörter: DISEASES::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Female::Uterine Neoplasms::Endometrial Neoplasms, Lurbinectedin, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales femeninos::neoplasias uterinas::neoplasias endometriales, Other subheadings::Other subheadings::Other subheadings::/drug therapy, Neutropenia, Other subheadings::Other subheadings::/therapeutic use, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, Research, Otros calificadores::Otros calificadores::/uso terapéutico, Medicaments antineoplàstics - Ús terapèutic, Pharmacologie, Endometri - Càncer - Tractament, Phase 2, 3. Good health, Endometrial Neoplasms, Cancérologie, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos, Endometrial cancer, Doxorubicin, Female, Humans, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Carbolines/adverse effects, Doxorubicin/therapeutic use, Endometrial Neoplasms/drug therapy, Endometrial Neoplasms/pathology, Neutropenia/chemically induced, Antineoplastic Combined Chemotherapy Protocols, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents, Carbolines
Dateibeschreibung: application/pdf; 1 full-text file(s): application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37556023
https://hdl.handle.net/20.500.12530/97687
https://hdl.handle.net/11351/10433
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=19420
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_124EFD9C766F0
https://serval.unil.ch/notice/serval:BIB_124EFD9C766F
https://serval.unil.ch/resource/serval:BIB_124EFD9C766F.P001/REF.pdf -
6
Autoren: et al.
Weitere Verfasser: et al.
Quelle: New England Journal of Medicine. 388:2145-2158
Schlagwörter: Immune Checkpoint Inhibitors/administration & dosage, Endometrial Neoplasms/mortality, Neoplasm Recurrence, Local/etiology, Oncologie, DNA Mismatch Repair, Carboplatin, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Medicine and Health Sciences, Paclitaxel/adverse effects, Human health sciences, Humanized, Immune Checkpoint Inhibitors, Treatments in Oncology, Endometrial Neoplasms/drug therapy, Medicine (all), General Medicine, Hematology/Oncology, 3. Good health, Neoplasm Recurrence, Local/drug therapy, Local, Oncology, Antibodies, Monoclonal, Humanized/adverse effects, Humanized/administration & dosage, Female, Microsatellite Instability, Antibodies, Monoclonal, Humanized/administration & dosage, Paclitaxel, Antibodies, Monoclonal, Humanized, Sciences de la santé humaine, Antibodies, Endometrial Neoplasms/pathology, Local/drug therapy, Carboplatin/adverse effects, Immune Checkpoint Inhibitors/adverse effects, SDG 3 - Good Health and Well-being, Double-Blind Method, Paclitaxel/administration & dosage, Humans, dostarlimab, Antineoplastic Combined Chemotherapy Protocols/adverse effects, ICTS (Institute of Clinical and Translational Sciences), Carboplatin/administration & dosage, Gynecologic Oncology, Endometrial Neoplasms, Dostarlimab, Primary Advanced, Endometrial Cancer, Neoplasm Recurrence, Obstetrics/Gynecology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Neoplasm Recurrence, Local, Endometrial Neoplasms/genetics
Dateibeschreibung: application/pdf
-
7
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Journal of Obstetrics and Gynaecology Research. 49:2118-2125
Schlagwörter: recurrence, Sentinel Lymph Node Biopsy, Endometrial Neoplasms* / pathology, Sentinel Lymph Node* / surgery, endometrial carcinoma, Lymph Nodes / pathology, 3. Good health, Endometrial Neoplasms, Lymph Node Excision / methods, sentinel lymph nodes, death, lymphadenectomy, Humans, Lymph Node Excision, Female, Lymph Nodes, Sentinel Lymph Node* / pathology, Sentinel Lymph Node, Endometrial Neoplasms* / surgery, Retrospective Studies, Neoplasm Staging
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37286510
-
8
Autoren: et al.
Quelle: BMC Res Notes
BMC Research Notes, Vol 17, Iss 1, Pp 1-4 (2024)Schlagwörter: Proteomics, Science (General), Proteome, QH301-705.5, Phosphatidylethanolamines, Data Note, Endometrial cells, Endometrial Neoplasms, Phosphatidylcholine, Q1-390, Cell Line, Tumor, Liposomes, Phosphatidylcholines, Medicine, Humans, Female, LC-MS/MS, Biology (General), Female [MeSH], Proteomics/methods [MeSH], Cell Line, Tumor [MeSH], Endometrial Neoplasms/metabolism [MeSH], Data Notes, Humans [MeSH], Phosphatidylethanolamines/metabolism [MeSH], Phosphatidylcholines/metabolism [MeSH], Endometrial Neoplasms/pathology [MeSH], Proteome/metabolism [MeSH], Liposomes [MeSH]
-
9
Autoren: et al.
Quelle: J Cancer Res Clin Oncol
Schlagwörter: Aged, 80 and over, Adult, 0301 basic medicine, TCGA, Female [MeSH], Molecular subtypes, Aged, 80 and over [MeSH], Aged [MeSH], Adult [MeSH], Next generation-sequencing diagnostics, Humans [MeSH], Endometrial cancer, Middle Aged [MeSH], Endometrial Neoplasms/classification [MeSH], Exome Sequencing/methods [MeSH], Molecular surrogate markers, Endometrial Neoplasms/pathology [MeSH], Endometrial Neoplasms/genetics [MeSH], Research, Biomarkers, Tumor/genetics [MeSH], Prognosis [MeSH], Middle Aged, Prognosis, Endometrial Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Exome Sequencing, Biomarkers, Tumor, Humans, Female, Aged
-
10
Autoren: et al.
Quelle: RadioGraphics. 44
Schlagwörter: Humans, Female, Endometrial Neoplasms / pathology, Endometrial Neoplasms, Neoplasm Staging
-
11
Autoren: et al.
Quelle: Clinical Oncology, 35, 2, pp. e199-e205
Schlagwörter: recurrence, Radboudumc 17: Women's cancers Radiation Oncology, Radboud University Medical Center, survival, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Chemotherapy, Humans, Uterine Neoplasms/surgery/drug therapy, Serous/surgery, Adjuvant, radiotherapy, Aged, Neoplasm Staging, Retrospective Studies, Cystadenocarcinoma, uterine serous, Endometrial Neoplasms/pathology, Radboudumc 17: Women's cancers Gynaecology, Combined Modality Therapy, Cystadenocarcinoma, Serous, Endometrial Neoplasms, 3. Good health, Chemotherapy, Adjuvant, endometrial cancer, Uterine Neoplasms, Female
-
12
Autoren: et al.
Quelle: J Cancer Res Clin Oncol
Schlagwörter: Aged, 80 and over, Adult, ddc:610, Research, 610 Medizin, Overall survival · Outcome · Multimodal therapy · Surgery · Radiotherapy · Chemotherapy · Retrospective cohort study, Middle Aged, Prognosis, Combined Modality Therapy, Female [MeSH], Outcome, Aged, 80 and over [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Overall survival, Multimodal therapy, Retrospective Studies [MeSH], Middle Aged [MeSH], Endometrial Neoplasms/mortality [MeSH], Retrospective cohort study, Germany/epidemiology [MeSH], Survival Rate [MeSH], Endometrial Neoplasms/pathology [MeSH], Endometrial Neoplasms/epidemiology [MeSH], Prognosis [MeSH], Endometrial Neoplasms/therapy [MeSH], Chemotherapy, Combined Modality Therapy [MeSH], Surgery, Radiotherapy, Registries [MeSH], Endometrial Neoplasms, 3. Good health, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, Germany, Humans, Female, Registries, Retrospective Studies, Aged
Dateibeschreibung: application/pdf
-
13
Autoren: et al.
Weitere Verfasser: et al.
Quelle: International Journal of Gynecological Cancer, 34 (9), 1313 - 1321 (2024-09-02)
Schlagwörter: Endometrial Neoplasms, Sentinel Lymph Node, Humans, Female, Retrospective Studies, Middle Aged, Aged, Sentinel Lymph Node/pathology, Aged, 80 and over, Adult, Sentinel Lymph Node Biopsy/methods, Lymphatic Metastasis, Endometrial Neoplasms/pathology, Endometrial Neoplasms/genetics, Endometrial Neoplasms/classification, Neoplasm Staging, Sentinel Lymph Node Biopsy, Oncology, Obstetrics and Gynecology, Human health sciences, Surgery, Reproductive medicine (gynecology, andrology, obstetrics), Sciences de la santé humaine, Oncologie, Chirurgie, Médecine de la reproduction (Gynécologie, andrologie, obstétrique)
Relation: https://syndication.highwire.org/content/doi/10.1136/ijgc-2024-005711; urn:issn:1048-891X; urn:issn:1525-1438
Zugangs-URL: https://orbi.uliege.be/handle/2268/325858
-
14
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Gynecologic Oncology. 166:438-443
Schlagwörter: Positron Emission Tomography Computed Tomography / methods, Positron emission tomography-computed tomography, Sentinel Lymph Node* / surgery, Lymphatic metastasis, Endometrial Neoplasms* / diagnostic imaging, 03 medical and health sciences, 0302 clinical medicine, Sentinel lymph node biopsy, Positron Emission Tomography Computed Tomography, Humans, Lymph Nodes / surgery, Sentinel Lymph Node* / diagnostic imaging, Endometrial neoplasms, Sentinel Lymph Node Biopsy, Lymph Nodes / diagnostic imaging, Sentinel Lymph Node Biopsy / methods, Endometrial Neoplasms* / pathology, Lymph Nodes / pathology, Endometrial Neoplasms, 3. Good health, Lymphatic Metastasis, Lymphatic Metastasis / pathology, Lymphatic Metastasis / diagnostic imaging, Lymph Node Excision, Female, Lymph Nodes, Sentinel Lymph Node* / pathology, Sentinel Lymph Node, Endometrial Neoplasms* / surgery
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/35907682
-
15
Autoren: et al.
Quelle: BMC Cancer
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)Schlagwörter: Research, Carcinoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Hysterectomy, Endometrial sampling, Endometrial Neoplasms, 3. Good health, Endometrium, Endometrial cancer, Diagnosis, Carcinoma, Endometrioid/pathology [MeSH], Endometrium/surgery [MeSH], Female [MeSH], Neoplasm Grading [MeSH], Endometrial Neoplasms/surgery [MeSH], Hysterectomy [MeSH], Accuracy, Humans [MeSH], Retrospective Studies [MeSH], Carcinoma/pathology [MeSH], Neoplasm Staging [MeSH], Endometrial Neoplasms/pathology [MeSH], Endometrium/pathology [MeSH], Endometrial Neoplasms/diagnosis [MeSH], Humans, Female, Neoplasm Grading, Carcinoma, Endometrioid, RC254-282, Retrospective Studies, Neoplasm Staging
-
16
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Dadun. Depósito Académico Digital de la Universidad de Navarra
Universidad de NavarraSchlagwörter: Male, Endometritis/complications, Abnormal uterine bleeding, Endometrial Hyperplasia/complications, Endometrial Neoplasms/pathology, Endometrium, 03 medical and health sciences, Polyps/pathology, Uterine Diseases/pathology, Polyps, 0302 clinical medicine, Prediction model, Endometrial disease, Endometrial neoplasms, Ultrasonography, Humans, Uterine Hemorrhage/diagnostic imaging, Obstetrics & Reproductive Medicine, Uterine Diseases, Science & Technology, Hyperplasia, Hyperplasia/complications, IETA, 3215 Reproductive medicine, Obstetrics & Gynecology, Atrophy/complications, CANCER, Myoma, Precancerous Conditions/complications, Endometrial Neoplasms, 3. Good health, Endometrium/diagnostic imaging, Myoma/complications, Endometrial Hyperplasia, Uterine Neoplasms, 1114 Paediatrics and Reproductive Medicine, Female, Uterine Hemorrhage, Atrophy, Uterine Neoplasms/complications, Endometritis, Life Sciences & Biomedicine, Precancerous Conditions
Dateibeschreibung: application/pdf
Zugangs-URL: https://www.karger.com/Article/Pdf/522524
https://pubmed.ncbi.nlm.nih.gov/35152217
https://hdl.handle.net/10171/116512
https://cris.maastrichtuniversity.nl/en/publications/071fcfca-6a62-42db-8f4c-1ac67db10f48
https://doi.org/10.1159/000522524
https://lirias.kuleuven.be/handle/20.500.12942/690473
https://doi.org/10.1159/000522524
https://hdl.handle.net/10281/365116
https://doi.org/10.1159/000522524 -
17
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Cancer Genomics - Proteomics. 19:747-760
Schlagwörter: Carcinosarcoma* / genetics, Carcinosarcoma* / pathology, mesonephric-like adenocarcinoma, Uterus, Endometrial Neoplasms* / pathology, carcinosarcoma, mesonephric-like carcinosarcoma, Adenocarcinoma, Prognosis, Endometrial Neoplasms* / genetics, Endometrial Neoplasms, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Carcinosarcoma, Humans, Female, Adenocarcinoma* / pathology, TP53, tumor protein 53
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36316041
-
18
Autoren: et al.
Quelle: J Cancer Res Clin Oncol
Schlagwörter: Ovarian Neoplasms, ERRalpha Estrogen-Related Receptor, ddc:610, 610 Medizin, Prognosis, Adenocarcinoma, Mucinous, Cystadenocarcinoma, Serous, Endometrial Neoplasms, 3. Good health, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, Receptors, Estrogen, Cystadenocarcinoma, Serous/pathology [MeSH], Ovarian Neoplasms/mortality [MeSH], Cystadenocarcinoma, Serous/metabolism [MeSH], Adenocarcinoma, Mucinous/mortality [MeSH], Endometrial Neoplasms/mortality [MeSH], Tissue microarray, Ovarian Neoplasms/metabolism [MeSH], Estrogen-related receptors, Adenocarcinoma, Clear Cell/metabolism [MeSH], Ovarian Neoplasms/pathology [MeSH], Adenocarcinoma, Mucinous/metabolism [MeSH], Female [MeSH], Endometrial Neoplasms/metabolism [MeSH], Follow-Up Studies [MeSH], Original Article – Cancer Research, Receptors, Estrogen/metabolism [MeSH], Ovarian cancer, Humans [MeSH], Overall survival, Retrospective Studies [MeSH], Cystadenocarcinoma, Serous/mortality [MeSH], Adenocarcinoma, Clear Cell/mortality [MeSH], Survival Rate [MeSH], Endometrial Neoplasms/pathology [MeSH], Adenocarcinoma, Clear Cell/pathology [MeSH], Biomarkers, Tumor/metabolism [MeSH], Adenocarcinoma, Mucinous/pathology [MeSH], Prognosis [MeSH], Progression-free survival, Estrogen-related receptors, Ovarian cancer, Overall survival, Progression-free survival, Tissue microarray, Biomarkers, Tumor, Humans, Female, Adenocarcinoma, Clear Cell, Follow-Up Studies, Retrospective Studies
Dateibeschreibung: application/pdf
Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00432-021-03673-9.pdf
https://pubmed.ncbi.nlm.nih.gov/34089362
https://link.springer.com/content/pdf/10.1007/s00432-021-03673-9.pdf
https://www.ncbi.nlm.nih.gov/pubmed/34089362
https://epub.uni-regensburg.de/45989/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310835
https://link.springer.com/article/10.1007/s00432-021-03673-9
https://pubmed.ncbi.nlm.nih.gov/34089362/
https://link.springer.com/article/10.1007/s00432-021-03673-9
https://doi.org/10.1007/s00432-021-03673-9
https://repository.publisso.de/resource/frl:6449854
https://epub.uni-regensburg.de/45989/ -
19
Autoren: et al.
Quelle: European Journal of Surgical Oncology. 47:1117-1123
Schlagwörter: Adult, Endometrial Neoplasms/mortality, Hysterectomy, Sciences de la santé humaine, Obese, Endometrial Neoplasms/pathology, 03 medical and health sciences, Elderly, 0302 clinical medicine, Endometrial cancer, Belgium, Robotic Surgical Procedures, BGOG, Robot-assisted surgery, Humans, Hysterectomy/methods, Obesity, Human health sciences, Aged, Neoplasm Staging, Retrospective Studies, Aged, 80 and over, Minimally-invasive surgery, Endometrial Neoplasms/surgery, Robotic Surgical Procedures/methods, General Medicine, Reproductive medicine (gynecology, andrology, obstetrics), Length of Stay, Middle Aged, Médecine de la reproduction (Gynécologie, andrologie, obstétrique), Conversion to Open Surgery, Endometrial Neoplasms, 3. Good health, Survival Rate, Length of Stay/statistics & numerical data, Oncology, Surgery, Female, Obesity/complications
-
20
Autoren: et al.
Weitere Verfasser: et al.
Quelle: J Cancer Res Clin Oncol
Schlagwörter: BRCA2 Protein, Ovarian Neoplasms, ddc:610, Heterozygote, Review – Clinical Oncology, BRCA1 Protein, Hormone Replacement Therapy, 610 Medizin, BRCA2 Protein/genetics [MeSH], Breast Neoplasms/etiology [MeSH], Genetic Predisposition to Disease [MeSH], Female [MeSH], Heterozygote [MeSH], Mutation [MeSH], Hormone Replacement Therapy/adverse effects [MeSH], Ovarian cancer, BRCA1 Protein/genetics [MeSH], Humans [MeSH], Breast cancer, Endometrial Neoplasms/etiology [MeSH], Hormone replacement therapy, Endometrial Neoplasms/pathology [MeSH], Ovarian Neoplasms/etiology [MeSH], Breast Neoplasms/pathology [MeSH], Ovarian Neoplasms/pathology [MeSH], Breast Neoplasms, Endometrial Neoplasms, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Hormone replacement therapy, Breast cancer, Ovarian cancer, BRCA1, BRCA2, Mutation, Humans, Female, Genetic Predisposition to Disease
Dateibeschreibung: application/pdf
Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00432-021-03629-z.pdf
https://pubmed.ncbi.nlm.nih.gov/33885953
https://link.springer.com/article/10.1007/s00432-021-03629-z
https://epub.uni-regensburg.de/45586/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164576
https://europepmc.org/article/MED/33885953
https://www.ncbi.nlm.nih.gov/pubmed/33885953
https://pubmed.ncbi.nlm.nih.gov/33885953/
https://resolver.sub.uni-goettingen.de/purl?gro-2/123220
https://repository.publisso.de/resource/frl:6449882
https://epub.uni-regensburg.de/45586/
Full Text Finder 
Nájsť tento článok vo Web of Science 
Full Text